$Sangamo Therapeutics (SGMO.US)$ added it was eligible to ea...

MakingProfit commented on a stock · Jul 26 15:52

$Sangamo Therapeutics (SGMO.US)$ added it was eligible to earn up to $220M in milestone payments and product sales royalties of 14% to 20% if the therapy is approved and commercialized. This is why i'm holding.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

11K Views

Comment

MakingProfit

14Followers

6Following

67Visitors